Misc Healthcare Topics
Ns: Parkinson's Disease
Compiled By Masterpiecesolutions
Edition: 2025/26
, Medical & Nursing | Misc Healthcare Topics I of V pages
1. Parkinsons disease is a progressive neurodegenerative condition resulting from what?
The death of dopaminergic cells in the substantia nigra in the brain.
2. Patients with Parkinsons disease classically present with motor-symptoms including what?
Patients with Parkinsons disease classically present with motor-symptoms including hypokinesia,
3. Non-motor symptoms of parkinsons disease include what?
Dementia
Sleep issues.
Depression
Bladder
Bowel dysfunction
Speech and language changes.
Swallowing problems
Weight loss
4. Patients with suspected Parkinsons disease should be referred to a specialist and reviewed at what
Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
When Parkinsons disease diagnosis is confirmed, patients should be advised to inform the DVLA and their car
5. Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
When Parkinsons disease diagnosis is confirmed, patients should be advised to inform the DVLA and their car
6. In early stages of Parkinsons disease, patients whose motor symptoms decrease their quality of life should
Levodopa combined with carbidopa (co-careldopa) or benserazide (co-beneldopa).
Carbidopa inhibits peripheral metabolism of levodopa, allowing a greater proportion of peripheral levodopa to
Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (DOPA decarboxylase inhibitor)
7. Parkinsons disease patients whose motor symptoms do NOT affect their quality of life could be prescribed a
Levodopa
Non-ergot derived dopamine-receptor agonists (pramipexole, ropinirole, rotigotine).
Monoamine-oxidase-B inhibitors (rasagiline or selegiline)
8. All dopaminergic therapy, but especially dopamine-receptor agonists, can cause what?
Impulse control disorders
9. Pramipexole is what type of drug?
Parkinsons disease patients whose motor symptoms do not affect their quality of life, could be prescribed a
of levodopa, non-ergot-derived dopamine-receptor agonists (pramipexole, ropinirole or rotigotine) or
10. Adverse reactions from antiparkinsonian drugs can include what?
Psychotic symptoms
Excessive sleepiness and sudden onset of sleep.
impulse control disorders
11. Rasagiline is what type of drug?
Misc Healthcare Topics 2025/26 Edition
Ns: Parkinson's Disease
Compiled By Masterpiecesolutions
Edition: 2025/26
, Medical & Nursing | Misc Healthcare Topics I of V pages
1. Parkinsons disease is a progressive neurodegenerative condition resulting from what?
The death of dopaminergic cells in the substantia nigra in the brain.
2. Patients with Parkinsons disease classically present with motor-symptoms including what?
Patients with Parkinsons disease classically present with motor-symptoms including hypokinesia,
3. Non-motor symptoms of parkinsons disease include what?
Dementia
Sleep issues.
Depression
Bladder
Bowel dysfunction
Speech and language changes.
Swallowing problems
Weight loss
4. Patients with suspected Parkinsons disease should be referred to a specialist and reviewed at what
Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
When Parkinsons disease diagnosis is confirmed, patients should be advised to inform the DVLA and their car
5. Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
Patients with suspected Parkinsons disease should be referred to a specialist and reviewed every 6 to 12
When Parkinsons disease diagnosis is confirmed, patients should be advised to inform the DVLA and their car
6. In early stages of Parkinsons disease, patients whose motor symptoms decrease their quality of life should
Levodopa combined with carbidopa (co-careldopa) or benserazide (co-beneldopa).
Carbidopa inhibits peripheral metabolism of levodopa, allowing a greater proportion of peripheral levodopa to
Benserazide is a peripherally-acting aromatic L-amino acid decarboxylase (DOPA decarboxylase inhibitor)
7. Parkinsons disease patients whose motor symptoms do NOT affect their quality of life could be prescribed a
Levodopa
Non-ergot derived dopamine-receptor agonists (pramipexole, ropinirole, rotigotine).
Monoamine-oxidase-B inhibitors (rasagiline or selegiline)
8. All dopaminergic therapy, but especially dopamine-receptor agonists, can cause what?
Impulse control disorders
9. Pramipexole is what type of drug?
Parkinsons disease patients whose motor symptoms do not affect their quality of life, could be prescribed a
of levodopa, non-ergot-derived dopamine-receptor agonists (pramipexole, ropinirole or rotigotine) or
10. Adverse reactions from antiparkinsonian drugs can include what?
Psychotic symptoms
Excessive sleepiness and sudden onset of sleep.
impulse control disorders
11. Rasagiline is what type of drug?
Misc Healthcare Topics 2025/26 Edition
